Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $84

Benzinga Newsdesk www.benzinga.com Negative 47.3%

Neg 47.3% Neu 0% Pos 0%

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $86 to $84.